梁浩;赵黎明;孙玉学;娄岳;张韶;刘阳;高涛;郭高超;栗超跃;

• 1:河南大学人民医院
• 2:河南省人民医院

摘要(Abstract)：

目的研究联合脑血运重建术治疗老年烟雾病患者临床效果。方法回顾性分析2017-01—2019-12河南省人民医院烟雾病诊疗中心收治的老年烟雾病患者(年龄>60岁)共52例,分为2组,联合脑血运重建组39例,保守治疗组13例,收集患者一般资料、临床特征、围术期并发症、神经功能并发症和改良Rankin量表(m RS)评分。结果长期随访后,联合脑血运重建组新发卒中5例(12.82%),保守治疗组新发卒中7例(53.84%);mRS评分改善情况:联合脑血运重建组33例(84.62%)明显改善,保守治疗组仅1例(7.69%);2组患者新发卒中事件(χ2=9.244,P=0.002)、mRS评分改善情况(χ2=4.675,P<0.001)差异均有统计学意义。结论联合脑血运重建术可明显改善老年烟雾病脑血流供应,降低mRS评分,提高老年烟雾病患者生活质量。

关键词(KeyWords)： 烟雾病;老年人;联合脑血运重建;生活质量;新发卒中

Abstract:

Keywords:

基金项目(Foundation): 河南省医学科技攻关计划省部共建青年项目（编号：SB201902027）

作者(Authors): 梁浩;赵黎明;孙玉学;娄岳;张韶;刘阳;高涛;郭高超;栗超跃;

参考文献(References)：

• [1]SCOTT R M,SMITH E R.Moyamoya Disease and Moyamoya Syndrome[J].N Engl J Med,2009,360(12):1226-1237.DOI:10.1056/NEJMra0804622.
• [2]SUZUKI J,TAKAKU A.Cerebrovascular"Moyamoya"Disease Disease Showing Abnormal Net-Like Vessels in Base of Brain[J].Arch Neurol,1969,20:288-299.DOI:10.1001/archneur.1969.00480090076012.
• [3]FUJIMURA M,TOMINAGA T.Current status of revascularization surgery for Moyamoya disease:special consideration for its'internal carotid-external carotid (IC-EC)conversion'as the physiological reorganization system[J].Tohoku J Exp Med,2015,236(1):45-53.DOI:10.1620/tjem.236.45.
• [4]ZHAO M,ZHANG D,WANG S,et al.The Collateral Circulation in Moyamoya Disease:A Single-Center Experience in 140 Pediatric Patients[J].Pediatr Neurol,2017,77:78-83.DOI:10.1016/j.pediatrneurol.2017.08.016.
• [5]BALTSAVIAS G,KHAN N,VALAVANIS A.The collateral circulation in pediatric moyamoya disease[J].Childs Nerv Syst,2015,31(3):389-398.DOI:10.1007/s00381-014-2582-5.
• [6]胡淼，余金，苏康，等.烟雾病的研究进展[J].中国实用神经疾病杂志，2019,22(15):1736-1740.DOI:10.12083/SYSJ.2019.15.253.
• [7]GROSS B A,DU R.Adult moyamoya after revascularization[J].Acta Neurochir (Wien),2013,155 (2):247-254.DOI:10.1007/s00701-012-1545-4.
• [8]HERVE D,IBOS-AUGE N,CALVIERE L,et al.Predictors of clinical or cerebral lesion progression in adult moyamoya angiopathy[J].Neurology,2019,93(4):e388-e397.DOI:10.1212/WNL.0000000000007819.
• [9]SUZUKI H,MIKAMI T,ENATSU R,et al.Gelastic attack in a child with moyamoya disease[J].Neurology,2018,91(3):141-142.DOI:10.1212/WNL.0000000000005826.
• [10]THO-CALVI S C,THOMPSON D,SAUNDERS D,et al.Clinical features,course,and outcomes of a UK cohort of pediatric moyamoya[J].Neurology,2018,90(9):763-770.DOI:10.1212/WNL.0000000000005026.
• [11]KIM T,LEE H,BANG J S,et al.Epidemiology of Moyamoya Disease in Korea:Based on National Health Insurance Service Data[J].J Korean Neurosurg Soc,2015,57(6):390-395.DOI:10.3340/jkns.2015.57.6.390.
• [12]MATSUSHIMA T,INOUE T,SUZUKI S O,et al.Surgical treatment of moyamoya disease in pediatric patients--comparison between the results of indirect and direct revascularization procedures[J].Neurosurgery,1992,31(3):404-405.DOI:10.1227/00006123-199209000-00003.
• [13]HAYASHI K,HORIE N,IZUMO T,et al.A nationwide survey on unilateral moyamoya disease in Japan[J].Clin Neurol Neurosurg,2014,124(7):1-5.DOI:10.1016/j.clineuro.2014.06.010.
• [14]BAO X Y,WANG Q N,ZHANG Y,et al.Epidemiology of Moyamoya Disease in China:Single-Center,Population-Based Study[J].World Neurosurg,2019,122:917-923.DOI:10.1016/j.wneu.2018.10.175.
• [15]ZHAO F,DUAN L,HAN C,et al.Clinical features,treatment,and outcomes of moyamoya disease in the elderly[J].Int J Cerebrovasc Dis,2018,11(26):829-831.DOI:10.3760/cma.j.issn.1673-4165.2018.11.005.
• [16]HOUKIN K,KAMIYAMA H,ABE H,et al.Surgical therapy for adult moyamoya disease.Can surgical revascularization prevent the recurrence of intracerebral hemorrhage?[J].Stroke,1996,27(8):1342-1346.
• [17]AGARWALLA P K,STAPLETON C J,PHILLIPS M T,et al.Surgical outcomes following encephaloduroarteriosynangiosis in North American adults with moyamoya[J].J Neurosurg,2014,121(6):1394-1400.DOI:10.3171/2014.8.Jns132176.
• [18]ZHAO L,SUN W,LIANG H,et al.Therapeutic effect of autologous bone marrow stem cell mobilization combined with anti-infective therapy on moyamoya disease[J].Saudi J Biol Sci,2020,27(2):676-681.DOI:10.1016/j.sjbs.2019.12.016.
• [19]CHIBA T,SETTA K,SHIMADA Y,et al.Comparison of Effects between Clopidogrel and Cilostazol on Cerebral Perfusion in Nonsurgical Adult Patients with Symptomatically Ischemic Moyamoya Disease:Subanalysis of a Prospective Cohort[J].J Stroke Cerebrovasc Dis,2018,27(11):3373-3379.DOI:10.1016/j.jstrokecerebrovasdis.2018.07.041.
• [20]MIYOSHI K,CHIDA K,KOBAYASHI M,et al.Two-Year Clinical,Cerebral Hemodynamic,and Cognitive Outcomes of Adult Patients Undergoing Medication Alone for Symptomatically Ischemic Moyamoya Disease Without Cerebral Misery Perfusion:A Prospective Cohort Study[J].Neurosurgery,2018,27(11):3373-3379.DOI:10.1093/neuros/nyy234/5025492.
• [21]CHO W S,CHUNG Y S,KIM J E,et al.The natural clinical course of hemodynamically stable adult moyamoya disease[J].J Neurosurg,2015,122(1):82-89.DOI:10.3171/2014.9.JNS132281.
• [22]KURODA S,HOUKIN K.Bypass Surgery for Moyamoya Disease:Concept and Essence of Surgical Techniques[J].Neurol Med Chir (Tokyo),2012,2012(5):96-102.DOI:10.2176/nmc.52.287.
• [23]JIANG H,NI W,XU B,et al.Outcome in adult patients with hemorrhagic moyamoya disease after combined extracranial-intracranial bypass[J].J Neurosurg,2014,121(5):1048-1055.DOI:10.3171/2014.7.JNS132434.
• [24]MIYAMOTO S,YOSHIMOTO T,HASHIMOTO N,et al.Effects of extracranial-intracranial bypass for patients with hemorrhagic moyamoya disease:results of the Japan Adult Moyamoya Trial[J].Stroke,2014,45(5):1415-1421.DOI:10.1161/STROKEAHA.113.004386.
• [25]KIM D S,HUH P W,KIM H S,et al.Surgical treatment of moyamoya disease in adults combined direct and indirect vs.indirect bypass surgery[J].Neurol Med Chir,2012,52(5):333-338.DOI:10.2176/nmc.52.333.
• [26]YOSHIDA Y,YOSHIMOTO T,SHIRANE R,et al.Clinical course,surgical management,and long-term outcome of moyamoya patients with rebleeding after an episode of intracerebral hemorrhage[J].Stroke,1999,30(11):2272-2276.DOI:10.1161/01.str.30.11.2272.
• [27]孙玮良，赵黎明，梁浩，等.烟雾病的临床特征及外科治疗的流行病学分析[J].中国实用神经疾病杂志，2020,23(6):485-490.DOI:10.12083/SYSJ.2020.06.025.
• [28]KAZUMATA K,ITO M,TOKAIRIN K,et al.The frequency of postoperative stroke in moyamoya disease following combined revascularization:a single-university series and systematic review[J].J Neurosurg,2014,121(2):432-440.DOI:10.3171/2014.1.JNS13946.
• [29]KIM H,JANG D K,HAN Y M,et al.Direct Bypass Versus Indirect Bypass in Adult Moyamoya Angiopathy with Symptoms or Hemodynamic Instability:A Metaanalysis of Comparative Studies[J].World Neurosurg,2016,94:273-284.DOI:10.1016/j.wneu.2016.07.009.
• [30]LAHTEENVUO J,ROSENZWEIG A.Effects of aging on angiogenesis[J].Circ Res,2012,110(9):1252-1264.DOI:10.1161/CIRCRESAHA.111.246116.
• [31]FUNAKI T,TAKAHASHI J C,TAKAGI Y,et al.Unstable moyamoya disease:clinical features and impact on perioperative ischemic complications[J].J Neurosurg,2015,122 (2):400-407.DOI:10.3171/2014.10.JNS14231.